Detailed explanation of contraindications for lorlatinib

Lorlatinib, also known as lorlatinib, is an important drug in the field of contemporary medicine, especially in the treatment of anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer. However, like all drugs, lorlatinib also has its specific contraindications, which require strict attention from patients and doctors.

Although lorlatinib is effective, it is not suitable for everyone. First of all, it is strictly prohibited for patients who are allergic to this drug. Allergic reactions may include, but are not limited to, rash, difficulty breathing and other symptoms. Once they occur, you should stop taking the medication and seek medical advice immediately. Therefore, it is important to understand the patient's allergic history before using lorlatinib.

Additionally, lorlatinib may have effects on the heart. Patients with a history of heart disease or compromised cardiac function should undergo a complete cardiac evaluation before use. At the same time, patients with hypertension should ensure that their blood pressure is under stable control before starting medication to avoid possible cardiovascular risks.

Pregnant and breastfeeding women are also contraindicated in lorlatinib. Because this medication may pose unknown risks to the fetus or infant, its use should be avoided during this special period.

In addition to the above contraindications, patients need to inform their doctors about other medications they are taking, including prescription drugs, over-the-counter drugs, and supplements, before using lorlatinib. This is because lorlatinib may interact with other medications, affecting efficacy or increasing the risk of side effects.

Finally, patients with hepatic impairment should also use caution when using lorlatinib. Since drugs are primarily metabolized in the liver, hepatic insufficiency may affect drug clearance and metabolism, thereby increasing the likelihood of adverse reactions.

In short, although lorlatinib is an effective anti-tumor drug, drug contraindications must be strictly observed when using it to ensure patient safety. If you have any questions or discomforts, you should communicate with your doctor in time to ensure scientific medication and safe treatment.

Reference materials:https://www.lorbrena.com/